State Street’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

State Street’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,230,831	Closed	-$73.6M	–	3886
2020 Q2	$73.6M	Buy	1,230,831 +577,230	+88%	+$35.7M	0.01%	1173
2020 Q1	$38.8M	Buy	653,601 +43,540	+7%	+$2.54M	﹤0.01%	1416
2019 Q4	$33.4M	Buy	610,061 +359,287	+143%	+$13.4M	﹤0.01%	1799
2019 Q3	$7.08M	Buy	250,774 +10,668	+4%	+$391K	﹤0.01%	2625
2019 Q2	$7.97M	Buy	240,106 +153,044	+176%	+$4.78M	﹤0.01%	2601
2019 Q1	$2.96M	Buy	87,062 +8,634	+11%	+$275K	﹤0.01%	2997
2018 Q4	$2.15M	Buy	+78,428	New	+$2.02M	﹤0.01%	3091

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

State Street's PRNB Position: Q3 2020 in Review

State Street sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 1,230,831 shares — an estimated $73.6M sold.

State Street first reported a position in PRNB in Q4 2018 and held it in 7 quarters. The position peaked at $73.6M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

State Street reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
State Street sold 1,230,831 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $73.6M.
State Street first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 7 quarters.
State Street's Principia Biopharma Inc. Common Stock position peaked at $73.6M in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on State Street's 13F filing for Q3 2020, filed 10 Nov 2020.